General Description
Decamethonium bromide is a depolarizing neuromuscular blocking agent that was historically used as a muscle relaxant during surgical procedures. It consists of two quaternary ammonium groups linked by a ten-carbon methylene chain. Unlike succinylcholine, decamethonium is not metabolized by plasma cholinesterase and has a longer duration of action, which limited its clinical utility.
Mechanism of Action
Decamethonium acts as an agonist at nicotinic acetylcholine receptors at the motor endplate, causing persistent depolarization of the postsynaptic membrane. This sustained depolarization initially triggers fasciculations followed by flaccid paralysis as sodium channels become inactivated.
Application
Decamethonium was used as an adjunct to general anesthesia to provide skeletal muscle relaxation during endotracheal intubation and surgery. Its use has been largely abandoned in favor of succinylcholine for short procedures and non-depolarizing agents for longer cases due to unpredictable duration, lack of reversibility, and the risk of prolonged apnea.